White Papers

Optimizing The Quantity and Quality of GLP-1 Weight Loss: Evidence from a 12-Week Comparative Study

04/10/2026

GLP‑1 medications have changed what’s possible for weight loss, but they also raise a critical question: what are people losing—fat, lean mass, or both? Omada’s Insights Lab conducted a 12‑week.

GLP-1s are Changing Americans’ Bodies–But Not in the Way You Think

02/11/2026

Demand for GLP-1 agonists has been steadily climbing. From 2019 to 2023, the number of patients without diabetes who started GLP-1 treatment for obesity rose 700%; and demand for these ‘miracle’.

Weight Health at One Year: Outcomes from Omada's Enhanced GLP-1 Care Track

01/08/2026

Medication therapy and lifestyle support go hand in hand in obesity care, especially when we consider GLP-1s. The Omada Insights Lab evaluated outcomes in the Enhanced GLP-1 Care Track at one year,.

Webinars & Events

NEBGH Cardiometabolic Health as a Business Imperative

03/16/2026

We’re thrilled to join the NEBGH Cardiometabolic Health as a Business Imperative Conference for the first time. This event brings together senior HR, benefits, and healthcare leaders for a strategic.

HLTH: 2026 Sponsor

02/24/2026

We’re proud to return as a sponsor of HLTH 2026 in Las Vegas. As the premier event for healthcare innovation, HLTH brings together more than 12,000 leaders, executives, and visionaries shaping the.

AHIP: 2026 Bronze Sponsor

02/24/2026

Omada Health is heading to Las Vegas for AHIP 2026, the industry’s flagship conference. This premier event brings together leaders, innovators, and change-makers from across the health insurance.

Keep Browsing

See All Posts
Become an Omada Insider
Sign Up